Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study

समान संसाधन

• A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
  द्वारा: Candelaria, Myrna, और अन्य
  प्रकाशित: (2007)
• Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
  द्वारा: Cetina, Lucely, और अन्य
  प्रकाशित: (2007)
• A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
  द्वारा: Arce, Claudia, और अन्य
  प्रकाशित: (2007)
• Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
  द्वारा: Chavez-Blanco, Alma, और अन्य
  प्रकाशित: (2005)
• Hydralazine target: From blood vessels to the epigenome
  द्वारा: Arce, Claudia, और अन्य
  प्रकाशित: (2006)